Research & Development

First “6” Achievements In Malaysia

null
null

First to develop a commercial process for extracting Palm Tocotrienols

null
null

First to develop a self-emulsifying SupraBio™ system

null
null

First to have a soft gelatin encapsulation plant

null
null

First to produce film-coated analgesics, softgel capsules & effervescent tablets

null
null

First to produce antibiotics in dispersible tablet form

null
null

First to develop patented technologies in drug delivery systems

It’s a long term battle:
Disease Vs Innovation

We always believe that only with great passion, will we be able to strive harder to achieve greater success and recognition in healthcare services. Innovation is the key path to develop new patented formulation for the prevention and treatment of diseases.

We fight to improve people’s health


A group of 40 professional scientists and laboratory executives, with only one common objective, which is intended to improve patients’ lives via new product development, pharmaceutical stability and bioequivalence (BE) studies.

Pharmaceutical stability
& bioequivalence studies

Apart from developing new products, our R&D team which is known as Attest Research Sdn Bhd focuses on stability & bioequivalence studies too. The 2 parameters are critical in ensuring the quality and consistency of Hovid’s products, and these are all part of Hovid’s efforts in ensuring the best for our customers.

In Malaysia, there are only a handful of centres certified and recognized by the Ministry of Health, Malaysia that are able to conduct BE studies. As part of clinical assurance, bioequivalence ensures the quality, efficacy and safety of pharmaceutical products reach the highest levels. To keep pace with the increasing demand for BE, Hovid has set up a large facility in Bayan Lepas, Penang to house clinical facilities with cutting-edge technology and at the same time, providing a comfortable environment for volunteers participating in the BE studies. Part of Hovid’s R&D team is based in this centre focusing mainly on BE studies while another team is based in Hovid’s manufacturing plant in Chemor, Perak.

R&D Lab
Hovid R&D Lab

Qualified facilities to
tailor to our customer’s needs

  • Largest pharmaceutical R & D centre in the private sector
  • The only other BE center recognized by the Ministry of Health Malaysia

What we do

product

Product development

  • Solid, semi-solid and liquid oral dosage forms
  • Topical preparations, including emulsions, suspensions, creams and ointments
  • Soft gelatin preparations
formula

Drug delivery system

  • Controlled release formulation
  • Enhanced oral bioavailability formulation
testing

Stability study & testing

Under the conditions of:

  • 25°C ± 2°C / 60% ± 5% RH
  • 30°C ± 2°C / 75% ± 5% RH
  • 40°C ± 2°C / 75% ± 5% RH
service

Clinical services

  • Bioequivalance (BE) studies
  • Bioavailability (BA) studies
  • Efficacy studies